Equity - Warrants (Details) - Warrants |
12 Months Ended | |
|---|---|---|
|
Dec. 31, 2024
$ / shares
shares
|
Dec. 31, 2023
$ / shares
shares
|
|
| Number of Units | ||
| Outstanding balance, beginning | shares | 36,465,771 | |
| Exercised | shares | (41,540) | |
| Expired | shares | (1,606,605) | |
| Outstanding balance, ending | shares | 34,817,626 | 36,465,771 |
| Exercisable | shares | 34,817,626 | |
| Outstanding balance, beginning | $ / shares | $ 6.3 | |
| Exercised | $ / shares | 2.5 | |
| Expired | $ / shares | 7.48 | |
| Outstanding balance, ending | $ / shares | 6.26 | $ 6.3 |
| Exercisable | $ / shares | $ 6.26 | |
| Weighted average remaining contractual life (in years) | ||
| Outstanding | 1 year 2 months 4 days | |
| Exercised | 3 months 29 days | |
| Exercisable | 1 year 2 months 26 days | |
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that are exercisable and can be converted under the plan. No definition available.
|
| X | ||||||||||
- Definition Per share or unit weighted-average exercise price of award under share-based payment arrangement that are currently exercisable and can be converted. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options that are exercisable, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were expired during the reporting period. No definition available.
|
| X | ||||||||||
- Definition The weighted average exercise price pertaining to an equity-based award plan other than a stock (or unit) option plan that were not exercised and are expired. No definition available.
|
| X | ||||||||||
- Definition Per share or unit weighted-average exercise price of nonvested award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Definition The weighted average exercise price pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for vested equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|